On Friday, Mar 28th, I bought shares of GILD right at the 200-ma for a bounce play, this is one of the strongest biotech stocks and should continue to hold in an uptrend for at least a little while as its hit drug is tracking huge numbers in the market and the pipeline is strong, I think a buy here for a couple dollars bounce could definitely be playable as the RSI is oversold, and the 200 MA is being defended strongly
Comments
justatrader
⋅
I sold at 74 levels and booked profits at 68 (long term ma). The risk for me is that gild should make a higher high and i'll buy on a dip. Currently charts are painting a bit bearish. Peak, low, lower high and then a low.
shomikghosh2
⋅
Definitely agree. This is only a bounce play for me for a couple percentage points. The RSI is oversold, outside lower bollinger band, and 200 ma should provide support from defenders trying to protect longer term uptrend